Professur für Translationale Frauenheilkunde und Geburtshilfe

Spatial expression of claudin 18.2 in matched primaries and metastases of tubo-ovarian carcinoma of all subtypes (2024) Wagner P, Gaß P, Pöschke P, Eckstein M, Gloßner L, Hartmann A, Beckmann M, et al. Journal article Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer (2024) Fasching P, Decker T, Hartkopf A, Nusch A, Heinrich BJ, Kurbacher C, Fuchs R, et al. Journal article Status quo and future directions of digitalization in gynecology and obstetrics in Germany: a survey of the commission Digital Medicine of the German Society for Gynecology and Obstetrics (2024) Pfob A, Hillen C, Seitz K, Griewing S, Becker S, Bayer C, Wagner U, et al. Journal article Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negative breast cancer (2024) Heger L, Heidkamp GF, Amon L, Nimmerjahn F, Bäuerle T, Maier A, Erber R, et al. Journal article Perspectives of patients and clinicians on big data and AI in health: a comparative empirical investigation (2024) Hummel P, Braun M, Bischoff S, Samhammer D, Seitz K, Fasching P, Dabrock P Journal article Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells - The DETECT III Clinical Trial (2024) Fehm T, Mueller V, Banys-Paluchowski M, Fasching P, Friedl TW, Hartkopf A, Huober J, et al. Journal article A content-based review of mobile health applications for breast cancer prevention and education: Characteristics, quality and functionality analysis (2024) Altmannshofer S, Flaucher M, Beierlein M, Eskofier B, Beckmann M, Fasching P, Hübner H Journal article, Review article Predicting mammographic density with linear ultrasound transducers (2023) Behrens A, Fasching P, Schwenke E, Gaß P, Häberle L, Heindl F, Heusinger K, et al. Journal article Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant (2023) Neven P, Fasching P, Chia S, Jerusalem G, De Laurentiis M, Im SA, Petrakova K, et al. Journal article Neoadjuvant immunotherapy and chemotherapy regimens for the treatment of high-risk, early-stage triple-negative breast cancer: a systematic review and network meta-analysis (2023) Cortes J, Haiderali A, Huang M, Pan W, Schmid P, Akers KG, Park JE, et al. Journal article